US 10744193
Immunogenic RSV polypeptides
granted A61KA61K2039/523A61K2039/54
Quick answer
US patent 10744193 (Immunogenic RSV polypeptides) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/523, A61K2039/54, A61K2039/55, A61K2039/555